The Lynx Group
Association for Value-Based Care

AVBCC Summit Highlights

Conference Correspondent — December 11, 2020
In this session, a panel of experts share the Wall Street perspective on the opportunities and challenges ahead for cancer drug developers and healthcare providers.
Read Article

Conference Correspondent — December 9, 2020
Healthcare continues to adapt to the economic impact of the COVID-19 pandemic. In this session, industry experts discuss the underlying trends and economic realities of cancer care in the United States and global markets.
Read Article

Conference Correspondent — December 8, 2020
The increased complexity of new oncology drugs and the accelerated rate of their approval has led to greater demands from stakeholders across the cancer care continuum. In this session, panelists discuss oncology drug supply chain channels and how they are incorporated in the move to value-based care.
Read Article

Conference Correspondent — December 4, 2020
Numerous new innovations in stem-cell transplantation are coming to the market. In this session, experts offer the clinician, manufacturer, and payer perspectives regarding these new therapies.
Read Article

Conference Correspondent — December 3, 2020
As one of the largest operational oncology value-based payment models, OCM has been a driving force in cancer
Read Article

Conference Correspondent — December 2, 2020
Cancer care is complex and expensive, making a one-size-fits-all approach to drug benefit designs and coverages an unfavorable solution for patients with cancer. In this session, panelists discuss drug benefit reforms and the intended and unintended consequences of the recommended provisions.
Read Article

Conference Correspondent — December 1, 2020
With multiple stakeholders playing a key role in value-based contracting, the pharmaceutical industry faces many obstacles. In this session, experts discuss these obstacles and the strategies for overcoming them.
Read Article

Conference Correspondent — November 30, 2020
340B is a discount program for low-income areas that increases resources and allows for patient expansion. In this session, panelists discuss the accuracy of pricing, the current state of the program, and future developments.
Read Article

Conference Correspondent — November 24, 2020
In this session, industry leaders discuss defining clinical utility for genomic testing and make recommendations to ensure appropriate implementation in cancer care.
Read Article

Conference Correspondent — November 23, 2020
Technology can enhance the patient engagement experience, creating a willingness among patients to receive advice and counseling virtually. In this session, experts discuss the challenges of engaging patients and the future of technology in the healthcare system as it relates to cancer care.
Read Article

Page 2 of 8

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: